Cortical thickness mediates the effect of b-amyloid on episodic memory ABSTRACT Objective: To investigate the associations among b-amyloid (Ab), cortical thickness, and episodic memory in a cohort of cognitively normal to mildly impaired individuals at increased risk of vascular disease.
The amyloid hypothesis of Alzheimer disease (AD) suggests that b-amyloid (Ab) initiates a cascade of pathologic events that eventually lead to dementia. While much evidence argues in favor of this hypothesis, some fails to support it. 1 In addition, epidemiologic data indicate that vascular risk factors increase the incidence of a clinical diagnosis of AD 2 ; however, little is known regarding the effects of vascular risk factors on the Ab cascade.
The hypothetical model of dynamic biomarkers of the AD pathology cascade 3 provides an interesting framework to test the amyloid hypothesis and investigate the influence of vascular factors. The model proposes a temporal ordering of AD biomarkers, which may reflect an underlying pathophysiologic sequence: CSF Ab 42 and amyloid PET changes are detectable first, followed by CSF tau, hypometabolism on [ 18 F]-fluorodeoxyglucose-PET, atrophy on MRI, and finally cognitive deficits. The temporal ordering suggests that the relationship between Ab and cognitive impairment is less proximate and thus should be less evident than the relationship between neurodegenerative biomarkers and cognitive impairment. It also proposes that Ab accumulation reaches a plateau before the clinical diagnosis of AD, which implies that no (or a mild) relationship should be detectable past this point between Ab and the other biomarkers. At the present time, little is known or hypothesized about effects of vascular risk on this temporal cascade. The goal of this study was to assess the relationships among Ab, neurodegeneration, and episodic memory in a sample predominantly without dementia, enriched for vascular risk factors. We hypothesized that Ab would be associated with thinner cortex and that thinner cortex would in turn be associated with episodic memory deficits. METHODS Participants. This study included 67 participants aged 70 years or older who underwent Pittsburgh compound B (PIB)-PET scanning, 3-tesla MRI scanning, and cognitive testing. Participants were from the Aging Brain Project, a multisite program recruiting older adults with cognitive ability ranging from normal to mild impairment, many at increased risk of arteriosclerotic cardiovascular disease. Subjects were selected to represent a spectrum of vascular diseases, using the Framingham Coronary Risk Profile (FCRP), and had normal to mildly impaired cognition. Participants with severe or unstable medical illness, neurologic or major psychiatric conditions other than AD or vascular dementia, alcohol or substance abuse, significant head injury, or moderate to severe dementia were excluded as were 11 subjects with large cortical strokes. Clinical Dementia Rating scale scores were 0 (n 5 35), 0.5 (n 5 31), and 1 (n 5 1). Times between PIB-PET, MRI, and cognitive testing averaged approximately 3 months (range, 0-15).
Standard protocol approvals, registrations, and patient consents. Written informed consent was obtained from participants or their legal representatives under protocols approved by the Institutional Review Boards at all participating institutions.
Neuropsychological testing. Participants underwent neuropsychological testing with a uniform protocol previously described. 4 The Mini-Mental State Examination 5 was used as a standard clinical measure of global cognition. Verbal episodic memory was measured with a composite scale that was created using item response theory methods that have been previously described. 4 The composite scale was psychometrically matched with linear measurement properties using item response theory. 6 The scale incorporates items from the Memory Assessment Scale list learning task 7, 8 and was transformed to have a mean of 100 and SD of 15.
Vascular risk. We used the FCRP to measure vascular risk. This index represents a weighted sum of smoking, diabetes, hypertension, and low-and high-density lipoprotein cholesterol. 9 It was designed to predict the 10-year risk of coronary heart disease. In the present study, based on FCRP scores, 33 subjects (49.3%) had a 10-year risk lower that 10%, 11 subjects (16.4%) had a 10-year risk between 10% and 20%, and 23 subjects (34.3%) had a 10-year risk higher than 20%. Our sample had more individuals with high cardiovascular risk compared with the US population surveyed from 1988 to 1994, in which 34.5% of subjects aged 70 to 80 years had risk below 10%, 51.5% between 10% and 20%, and only 14% more than 20%. 10 Imaging data acquisition. Pittsburgh compound B. PIB was synthesized at Lawrence Berkeley National Laboratory using a previously published protocol. 11 All PIB-PET images were acquired using a Siemens ECAT EXACT HR PET scanner (Siemens Medical Systems, Erlangen, Germany) in 3-dimensional acquisition mode. Dynamic acquisition frames (35 frames total) were obtained over 90 minutes after the injection of 10 to 15 mCi of [ 11 C] PIB.
Structural MRI. We acquired structural MRI scans on 3-tesla systems, using sequences that had been harmonized by implementing the Alzheimer's Disease Neuroimaging Initiative (ADNI) scan parameters at each MRI site, then scanning the ADNI phantom to test for signal-to-noise ratio. Images included a T1-weighted volumetric magnetization-prepared rapid-acquisition gradient echo scan (repetition time [TR] 5 2,500, echo time [TE] 5 2.98, inversion time [TI] 5 1,100 milliseconds, 1 3 1 3 1 mm 3 isotropic resolution) and a fluid-attenuated inversion recovery scan (TR 5 8,800, TE 5 495, TI 5 2,360 milliseconds, with 1 3 1 3 2 mm 3 resolution or TR 5 5,000, TE 5 430, TI 5 1,700 milliseconds, with 1 3 1 3 2 mm 3 resolution). Sixty participants were scanned at University of California, Davis on a Siemens Magnetom Trio system with an 8-channel head coil. Seven participants were scanned at University of California, San Francisco on a Siemens Magnetom TrioTim system with a 12-channel head coil. No frontal, parietal (precuneus), temporal, or occipital cortical thickness difference was found between the scanners (data not shown).
Imaging data processing. Pittsburgh compound B. We preprocessed PIB-PET data using the Statistical Parametric Mapping version 8 software package (http://www.fil.ion.ucl.ac.uk/spm). Regions of interest (ROIs), used to define the cerebellar reference region and to guide PIB-PET processing, were created with the FreeSurfer version 5.1 software package (http://surfer.nmr.mgh. harvard.edu). Frames 6 through 35 as well as the sum of frames 1 to 5 were realigned to the middle frame (17th frame). Realigned frames 1 to 23 (corresponding to the first 20 minutes of acquisition) were then averaged. This average volume was used to transform the MRI (and cerebellar reference region) to the native PET space. PIB distribution volume ratio images were calculated using Logan graphical analysis with PIB frames corresponding to 35 to 90 minutes postinjection and a gray matter masked cerebellar reference region. 12, 13 We created a global PIB index representing overall cortical Ab deposition by averaging the mean distribution volume ratio value from frontal (cortical regions anterior to the precentral gyrus), temporal (middle and superior temporal regions), parietal (supramarginal gyrus, inferior/superior parietal lobules, and precuneus), and posterior cingulate ROIs. These ROIs, as well as the ones used for cortical thickness, were created in each subject's native space using the Desikan-Killiany atlas and the semiautomated FreeSurfer processing stream. 14 Subjects with a PIB index value of 1.16 and higher were classified as having abnormal Ab deposition (PIB1) and those below this cutoff were considered PIB2. This cutoff was validated in an independent sample using a similar processing technique. 15 Structural MRI. We measured cortical thickness (mm) with FreeSurfer version 5.1. ROIs were defined by averaging weighted left and right frontal, parietal, temporal, occipital, and precuneus ROIs included in the Desikan-Killiany atlas. 14 Images were visually examined to ensure segmentation accuracy, and regions with poor image quality or misregistration were excluded from statistical analysis. We excluded the frontal ROI for 3 subjects, the parietal ROI for 2 subjects, the precuneus ROI for 2 subjects, the temporal ROI for 4 subjects, and the occipital ROI for 3 subjects.
Vascular brain injury. A neurologist identified infarcts (.3 mm) on T1-weighted images, and white matter hyperintensities were quantified on fluid-attenuated inversion recovery images using a semiautomated procedure previously described elsewhere. 16, 17 Intrarater and interrater reliability for this method is high and these data have been published previously. 18 Statistical analysis. Analyses were performed using SPSS version 20 (IBM Corp., Armonk, NY). Differences between groups for baseline analyses were conducted using 2-tailed Student t tests or Pearson x 2 tests. Linear regressions were used to test the relationship between global cortical Ab accumulation and cortical thickness in ROIs. Three regression models (all older adults, PIB1 and PIB2) were run for each ROI (frontal, parietal, precuneus, temporal, and occipital). Mediation analyses were then conducted among all older adults using path analyses. Mediation exists when a predictor affects a dependent variable indirectly through a third variable (the mediator). 19 Looking at figure 1, mediation would be represented by significant indirect (paths a*b) effects. Indirect effects were examined using a 95% bootstrapped bias-corrected confidence interval (BCI) 19 established via bootstrapping with 5,000 bootstrap samples. 20 The regression and the path analyses models were first conducted without covariates in order not to remove variance associated with Ab. 21 They were repeated, adjusted for age and for FCRP (in separate models), to test whether these factors influenced our findings. These adjustments were done using the standardized residuals after regressing each variable included in each model on age or FCRP. A p value ,0.05 was considered significant.
RESULTS Participant characteristics. Demographic, clinical, and MRI characteristics are presented in table 1. PIB1 and PIB2 participants did not differ on age, level of education, or APOE e4 status. There were trends for more men and more cognitively impaired persons (Clinical Dementia Rating score) in the PIB1 group compared with the PIB2 group. PIB1 subjects had increased vascular risk (FCRP score) compared with PIB2 subjects. PIB1 subjects performed worse on the episodic memory scale. A trend was found for thinner frontal cortex in PIB1 subjects compared with PIB2 subjects.
Relationship between Ab and cortical thickness. The following results are first presented without covariates, then controlling for age, and finally controlling for vascular risk (FCRP score). The analyses adjusted for FCRP are not adjusted for age. In this cohort, age was marginally associated with Ab (b 5 0.22, standard error 5 0.004, p , 0.08) and vascular risk was associated with Ab (b 5 0.35, standard error 5 0.004, p , 0.01).
When the relationship between Ab and cortical ROIs was assessed across all older adults, increased Ab was related to thinner frontal, parietal, and precuneus cortices (table 2). When these analyses were adjusted for age, the association with the precuneus was still significant but the association between Ab and thickness in the frontal and the parietal cortices became marginal (p , 0.08). No association between Ab and cortical thickness reached significance when controlling for FCRP.
When the analyses were restricted to PIB1 subjects (figure 2, table 2), Ab was negatively associated with frontal, parietal, precuneus, and occipital cortical thickness, but not with temporal thickness. Similar results were found when controlling for age. Only the associations with the precuneus and the occipital cortices were significant when controlling for FCRP. As expected, no association was found between Ab and cortical thickness in PIB2 subjects regardless of the covariates included in the models.
Relationships among Ab, cortical thickness, and memory.
The following results are first presented with no covariates. Then, the analyses were adjusted for age and FCRP by using the standardized residuals after regressing each variable in the model on age or FCRP. This was done to diminish the number of variables included in the analyses. These analyses were performed within the whole sample. Direct association between Ab and memory. Increased Ab was associated with lower episodic memory (figure 1). This result is consistent with the group difference found between PIB1 and PIB2 (table 1). Neither age nor FCRP was associated with memory performance; therefore, results were similar when controlling for these factors.
Direct association between cortical thickness and memory.
Thinner frontal, parietal, precuneus, temporal, and occipital regions were all associated with lower memory performance (table 3) . Results were unchanged when controlling for age or FCRP.
Mediating effect of cortical thickness on memory. We tested the mediating (indirect) effects of cortical thickness on the relationship between Ab and memory with path analyses. Figure 1 shows that thickness within the frontal, parietal, and precuneus cortices all mediate the effect of global cortical Ab on memory. On an exploratory basis, we also tested whether temporal or occipital thickness mediated the relationship between Ab and memory. Even though the direct association between Ab and temporal thickness did not reach significance (p 5 0.13), temporal thickness was found to mediate the effect of Ab on memory (b 5 20.06; BCI: 20.17, 20.004). Results were similar when adjusting for age except for the temporal lobe where the mediation model was no longer significant. When adjusting for FCRP, only the mediation model including the precuneus was significant (b 5 20.05; BCI: 20.15, 20.001). Indeed, when controlling for FCRP, the parietal, frontal, and temporal cortices no longer mediated the association between Ab and memory. DISCUSSION We found that increased Ab deposition was clearly associated with thinner cortex in persons with higher Ab levels. This relationship was seen throughout the cortex, except in the temporal lobe, providing strong evidence that Ab is a major factor associated with neuronal integrity in aging and highlighting its extensive effects. In addition, while many studies characterize individuals as "positive" or "negative" for fibrillar Ab in the brain, these results indicate that the amount of Ab is important in addition to its presence or absence (figure 2). These findings are consistent with previous studies suggesting that Ab deposition is associated with cortical thinning in aging. 22, 23 They further show that the inclusion of PIB2 subjects in analyses assessing the association between Ab on other biomarkers might diminish the strength of the results.
While controlling for age in these diverse analyses had only a small effect on the results, controlling for vascular risk (using the FCRP score) had a more dramatic effect. Indeed, when controlling for vascular risk, only the precuneus and the occipital cortices were negatively associated with Ab deposition in PIB1 subjects and no association reached significance when the analyses were conducted in the total sample. It is important to be careful when interpreting these results. Because Ab and vascular risk share common variance, 24,25 controlling for vascular risk probably diminishes the effect of amyloid that we are trying to capture. Therefore, these results do not imply that Ab has no effect on cortical thickness, but rather that both factors probably affect cortical thickness via similar mechanisms and that the effect of vascular risk is stronger than the effect of Ab in individuals without dementia. Vascular risk factors are well known to have a widespread effect on cortical thickness, 26, 27 which usually begin in early life. 28 This might explain why they overcome the effect of Ab in individuals without dementia. Compared with vascular pathology, AD pathology might therefore be associated with more severe neurodegeneration only in patients with dementia. 29 The relative effects of age and vascular risk in this study must also be interpreted with caution because this sample was specifically chosen for diversity in vascular disease but not age. Interestingly, even though vascular risk had an effect on cortical thickness in this study, only Ab was associated with worse verbal memory performance. In addition to their effect on cortical thickness, these 2 pathologies are known to impair neuronal networks. Ab for instance has a major effect on the default mode network, 30,31 a network intrinsically affected in AD 32 and involved in successful episodic memory. 31 The precuneus, a region found to be affected by Ab in PIB1 subjects when controlling for vascular risk in this study, is a major cortical hub of this network. 33 Vascular risk in turn is predominantly associated with dysfunction of the frontal-striatal system, a system essential for attention and executive functions where dysfunction may lead to more subtle memory impairment. 34 Together, these findings suggest that both factors may increase AD risk via cortical thinning, but in different brain regions and neural systems.
Our study provides evidence that cortical thickness in frontal and parietal (precuneus) lobes mediates the relationships between Ab and memory (figure 1). Indeed, Ab was found to influence cortical thickness, which in turn influenced memory. Furthermore, the association between Ab and memory was no longer significant when accounting for cortical thickness. When these analyses were controlled for vascular risk, only the precuneus was found to mediate the association between Ab and memory. Other factors such as tau pathology have also been suggested to mediate the relationship between Ab and memory, 35 possibly as an additional factor influencing cortical thickness and network integrity. Together, our findings suggest that cortical thickness has a major role in producing memory loss by mediating Ab effects in precuneus, while in other brain regions it seems likely that a combination of vascular factors and Ab may be important.
In concordance with other studies, 36, 37 our results underscore that Ab is not the only factor associated with cortical thinning in aging. This is particularly evident in figure 2, which shows that the variability in cortical thickness is similar between PIB1 and PIB2. Our results indicate that vascular factors account for part of this variability. Other factors such as neurofibrillary tangles, 38 genetic factors, 39 and brain reserve 40 probably also explain part of this variability. Finally, we cannot exclude the possibility that some subjects included in the PIB2 group were in the earliest stage of Ab accumulation, particularly because ambiguous cases were included in this group. 15 Both the sample size in this study and the differences in brain regions associated with Ab accumulation were small. However, only subjects with similar data acquisition were included because cortical thickness assessments are highly influenced by methodologic differences in data acquisition. Furthermore, the present study has the advantage of being multimodal, which allows exploration of the interactions among several biomarkers.
These results indicate complex relationships among Ab, vascular risk, cortical thinning, and memory. While Ab is associated with cortical thinning and cognitive decline, it is not the only factor leading to cortical thinning in aging. In this cross-sectional study of individuals without dementia, the effect of Ab on cortical thickness, but not on memory, seems to be overshadowed by vascular disease. These data argue that while Ab can be a good target for clinical trials, controlling vascular risk might have a major effect on AD.
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